Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2011 Jun 9;2011:bcr0220113872. doi: 10.1136/bcr.02.2011.3872

Isolated lower limb medium-vessel vasculitis: a new entity?

David Gore 1, Marwan Bukhari 2
PMCID: PMC3116294  PMID: 22691585

Abstract

A 47-year-old female was referred with bilateral ischaemic lesions affecting her toes with associated gangrene. Systemic examination was normal and her medical history was unremarkable. Close examination of the hands revealed splinter haemorrhages. Her feet were dusky in colour and the toes were dark and weeping, each becoming gangrenous, with erythema around the metatarsal phalangeal joint. Dorsalis pedis and posterior tibial pulses were intact with strong Doppler signals. Investigations for surgical pathology and malignancy were all negative as were routine blood tests and tests for autoimmune and viral markers. Vasculitis was diagnosed when her toes showed improvement with steroids, however, attempts to reduce the steroid dose were unsuccessful and azathioprine was introduced. Despite immunosuppression and immunomodulators, her toes deteriorated and were amputated. Histology revealed findings consistent with a medium-vessel vasculitis which antineutrophil cytoplasmic antibody was negative. A similar vasculitis has not been formally reported in the literature.

Background

This case of vasculitis had presented to rheumatology with negative autoimmune markers. In particular, it is noted that antineutrophil cytoplasmic antibody (ANCA) was negative. In addition to this, we note that the vasculitis had affected only the lower limb digits. This unique presentation of a vasculitis has the potential to cause a delay in diagnosis and therefore a delay in treatment. Given that delays in treatment can lead to irreversible damage of the organ or limbs affected,1 our case highlights the importance of considering vasculitidies even when autoimmune investigations are negative. Furthermore, to the best of our knowledge, isolated lower limb ANCA-negative medium-vessel vasculitidies are rarely reported in literature. Finally, the case highlights the difficulties faced when differentiating between and diagnosing vasculitidies.

Case presentation

A 47-year-old Caucasian female presented with bilateral ischaemic lesions affecting all of her toes with associated gangrene. Her history started in December 2008 when she attended her general practitioner (GP) having noticed her toes becoming pale blue and experiencing paresthesia, she had no history of exposure to cold. In March 2009, her toes had not improved and had become increasingly painful and dusky, her GP arranged admission to hospital.

Aside from hypothyroidism from the age of 20 and pernicious anaemia, her medical history was unremarkable. Her surgical history included a gastric bypass in 2004 (secondary to obesity) and a laparoscopic cholecystectomy in 2007, recently her weight had been stable. There was no significant family history. Social history revealed minimal alcohol intake and she was a non-smoker. Medication history revealed continuous use of the combined oral contraceptive pill (COCP) since she experienced menorrhagia aged 17 years. Systemic examination, including blood pressure and funduscopy, was normal. Close examination of the hands revealed splinter haemorrhages. Her feet were dusky in colour and the toes were dark and weeping, each becoming gangrenous with erythema around the metatarsal phalangeal joint (figure 1). Dorsalis pedis and posterior tibial pulses were intact with strong Doppler signals.

Figure 1.

Figure 1

(A,B) Initial presentation of dusky, gangrenous feet.

Investigations for surgical pathology and malignancy were all negative (table 1) as were investigations for autoimmune and viral markers (table 2)

Table 1.

Investigations for surgical pathology and malignancy

Investigation Result
Routine blood tests Hb: 13.8 g/dl (11.5–16.5)
WCC: 9.2×109 (4–10)
Kidney and liver functions normal (except for a γ-GT of 214)
Ferritin: 359
Inflammatory markers CRP: 40.2
ESR: 47
Tumour markers CEA: 4.0 (normal)
CA 12-5: 14.4 (normal)
CA 19-9 (normal)
USS venography Normal with no occlusions
Arterial angiography Normal
USS Doppler leg arteries Normal
USS abdomen Liver and aorta normal
CT abdomen and pelvis Normal
Echocardiography Normal
Urine Dip Traces of protein, blood and glucose
Serum cholesterol Fasting: 4.91 (HDL: 2.10, LDL: 2.45)

γ-GT, γ-glutamyltransferase; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; HDL, high-density lipoprotein; Hb, haemoglobin; LDL, low-density lipoprotein; USS, ultrasound scanning; WCC, white cell count.

Table 2.

Results of autoimmune and viral markers

Investigations Result
Autoimmune Antithrombin III-81 (normal)
Protein C 77% (normal)
Free protein S 84% (normal)
Lupus AC 0.96 (negative)
RF 6.7
Cryoglobulins Negative
ANCA Negative
Ab to nuclei Negative
Reticulin R1 Negative
Smooth muscle Ab Negative
Mitochondria (M2 and non-M2) Ab Negative
Liver, kidney, microsomal Ab Negative
Ribosomal Ab Negative
Anticardiolipin Ab Negative
Cold agglutinin titre Negative
Fibrinogen 8.4 (high) 1.5–4.5
Cryofibrinogen Negative
IgG 4.67 (low)
IgM 1.16 (normal)
IgA 1.24 (normal)
Serum electrophoresis Normal
Viral markers-Hep B Sag Negative
Hep C Ab Not detected
HIV Negative
Parvovirus Negative

Ab, antibody; ANCA, antineutrophil cytoplasmic antibody; Hep, hepatitis; Ig, immunoglobulin; RF, rheumatoid factor.

Differential diagnosis

  • Isolated vasculitis

  • Thromboangitis obliterans (Buerger’s disease)

  • Polyarteritis nodosa (PAN).

Treatment

She was asked to stop taking the COCP and was commenced on prednisolone 30 mg, her toes showed some improvement with the prednisolone and vasculitis was diagnosed. Attempts to reduce the steroid dose were unsuccessful and azathioprine was introduced. In January 2010, she was readmitted to hospital as her toes were worsening and becoming increasingly painful (figure 2). A course of iloprost was given followed by a dose of cyclophosphamide.

Figure 2.

Figure 2

(A,B) Deterioration of feet despite treatment.

Outcome and follow-up

Her toes showed mild improvement, however in February 2010, her toes worsened and became infected. Vascular surgeons amputated seven toes and samples were sent to histology. Histology revealed appearances consistent with a medium-vessel vasculitis, no micro aneurysms were noted and there was no inflammation of the small vessels. Unfortunately, cryoglobulins and cryofibrinogen were not looked for during histological examination. Postamputation healing is complete and symptoms have not re-occurred.

Discussion

The vasculitidies are defined as a group of multisystem diseases characterised by blood vessel inflammation,2 secondary to leucocyte infiltration of the vessel wall and reactive damage.3

The classification of vasculitidies is a debated area,4 however, typically they are classified according to vessel size and definitive diagnosis is always histological via tissue sampling/biopsy.4 Accurate diagnosis of the vasculitidies guides appropriate treatment, where the vasculitis cannot be classified and no diagnosis exists experience and clinical judgement are key.1

Our case highlights the difficulty in making an accurate diagnosis of digital ischaemia even with detailed investigations, as there are many differential diagnoses including Buerger’s disease,5 PAN6 and cryoglobulinaemia.

Buerger’s disease is a possible differential diagnosis. Although men are most commonly affected, there are isolated case reports of affected females5; however, the positive response to steroids does not support this diagnosis, nor does the negative smoking status or normal angiography. While PAN cannot be formally excluded, there was an absence of symptoms to meet the classification criteria7 and no microaneurysms on histology, making this diagnosis less likely. Mesenteric and renal angiograms can often aid in the confirmation or exclusion of PAN.8 The absence of exposure to cold enabled exclusion of cryoglobulinaemia as a differential, although we are aware of the limitation that cryoglobulins were not tested for during histology. Furthermore, there has been no recurrence of symptoms since the amputation and the feet have healed well. Finally the presence of splinter haemorrhages means a diagnosis of a systemic disease cannot be excluded as early ANCA-associated vasculitidies can be ANCA negative.9

Early treatment of vasculitis minimises disease associated damage,1 the most common treatments involve steroids and cytotoxic medications. During treatment, careful monitoring for disease remission and drug-induced toxicity are fundamental and guide treatment.10 For the classified vasculitidies the limited information available suggests that the treated outcomes are superior to untreated outcomes.10

To the best of our knowledge, an isolated lower limb ANCA-negative medium-vessel vasculitis has not been reported in the literature and may represent an unclassified vasculitis or new disease entity.

Learning points.

  • The diverse presentation of vasculitidies and the multitude of differential diagnoses means vasculitidies are often hard to precisely diagnose and diagnosis can potentially be missed and should always be considered.

  • Delays in the treatment of vasculitidies can result in permanent, often irreversible damage.

  • Digital ischaemia/gangrene can occur due to small vessel vasculitis without the presence of ANCA or other immunological markers.

Acknowledgments

Pathology Laboratory and staff at the University Hospitals of Morecambe Bay NHS Foundation Trust.

Footnotes

Competing interests None.

Patient consent Obtained.

References

  • 1.Ghetie D, Rudinskaya A, Raut R. The enigma of vasculitis. Int J Rheumatol 2010;2010:312159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Watts RA, Scott DG. Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol 2009;23:429–43 [DOI] [PubMed] [Google Scholar]
  • 3.Langford CA, Klippel JH, Balow JE, et al. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases. Ann Intern Med 1998;128(12 Pt 1):1021–8 [DOI] [PubMed] [Google Scholar]
  • 4.Basu N, Watts R, Bajema I, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010;69:1744–50 [DOI] [PubMed] [Google Scholar]
  • 5.Parvizi N, Shalhoub J, Davies AH. Buerger’s disease: a multidisciplinary diagnostic and therapeutic challenge. JRSM Short Rep 2010;1:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goon AT, Tay YK, Giam YC, et al. An unusual case of cutaneous vasculitis. Ann Acad Med Singap 2000;29:249–52 [PubMed] [Google Scholar]
  • 7.Lightfoot RW, Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088–93 [DOI] [PubMed] [Google Scholar]
  • 8.Oran I, Memis A, Parildar M, et al. Multiple intracranial aneurysms in polyarteritis nodosa: MRI and angiography. Neuroradiology 1999;41:436–9 [DOI] [PubMed] [Google Scholar]
  • 9.Stone JH. Clinical spectrum of antineutrophil cytoplasmic antibodies. UpToDate 2010. http://www.uptodate.com/contents/clinical-spectrum-of-antineutrophil-cytoplasmic-antibodies (accessed 10 May 2011). [Google Scholar]
  • 10.Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 2007;46:1615–16 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES